McDonald Ian → BRIGHT MINDS BIOSCIENCES INC. DRUG

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -26.4%

Passive Schedule 13G filer baseline
Moderate short days-to-cover (4.5 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 1 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.50

829,718 shares short · -6.0% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-28	Cormorant Asset Management, LP	—	Sale	109,331	$89.50	$9.79M

Other 13D/G Filings on BRIGHT MINDS BIOSCIENCES INC.

Filed	Form	Filer	Stake	Shares
2026-07-02	SCHEDULE 13D/A	McDonald Ian	13.70%	1,396,665	view →
2024-02-26	SC	McDonald Ian	—	—	view →

Other Filings by McDonald Ian

Filed	Form	Issuer	Stake	Shares
2026-07-02	SCHEDULE 13D/A	BRIGHT MINDS BIOSCIENCES INC. DRUG	13.70%	1,396,665	view →
2024-02-26	SC	BRIGHT MINDS BIOSCIENCES INC. DRUG	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →